GSK (GSK) shares have jumped $3.16, or 9% to $38.32 in afternoon trading, while shares of Sanofi (SNY) are up $3.36, or 7.5%, to $48.29. The two stocks moved in tandem previously amid headlines regarding Zantac litigation, so there is speculation that the moves this afternoon may be related to news regarding Zantac.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on GSK:
- GSK downgraded to Underperform from Neutral at BofA
- GSK price target lowered to 1,550 GBp from 1,975 GBp at Citi
- AnaptysBio, GSK announces Phase 3 RUBY trial results for JEMPERLI
- GSK reports EMA accepts marketing authorization application for momelotinib
- GSK’s phase 3 trial of Jemperli meets primary endpoint
